Literature DB >> 826770

Further observations on the value of oral penicillins in chronic staphylococcal osteomyelitis.

S M Bell.   

Abstract

This report confirms after periods of observation of up to nine years, the successful treatment with high oral doses of cloxacillin or phenoxymethylpenicillin of 19 patients suffering from chronic staphylococcal osteomyelits. The antibiotic treatment was closely supervised over long periods, and the satisfactory response initially reported has been maintained in each case. Brief reference is made also to the use of the same treatment in a further 191 patients with chronic staphylococcal bone infection. Observations of the progress of 136 of these patients are continuing. At this stage the response in these patients confirms the value in chronic osteomyelitis of the long-term treatment with these penicillins which was established in the first 19 patients treated.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826770

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  7 in total

1.  Defining criteria for the pharmacoeconomic evaluation of new oral cephalosporins.

Authors:  P G Davey; M Malek
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

Review 2.  Antimicrobial therapy. Cost-benefit considerations.

Authors:  B J Guglielmo; G F Brooks
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

3.  Treatment of osteomyelitis and septic arthritis.

Authors:  F A Waldvogel
Journal:  Bull N Y Acad Med       Date:  1982-11

Review 4.  Osteomyelitis. Common causes and treatment recommendations.

Authors:  D R Dirschl; L C Almekinders
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

5.  Current concepts in the management of infections in bones and joints.

Authors:  A S Dickie
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

6.  Long Bone Osteomyelitis.

Authors:  Luca Lazzarini; Fausto De Lalla; Jon T. Mader
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

7.  Ciprofloxacin concentrations in bone and muscle after oral dosing.

Authors:  I W Fong; W H Ledbetter; A C Vandenbroucke; M Simbul; V Rahm
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.